Total Payments
$223,905
2024 Payments
$29,607
Companies
32
Transactions
768
Medicare Patients
4,624
Medicare Billing
$360,825
Payment Breakdown by Category
Other$162,860 (72.7%)
Consulting$23,467 (10.5%)
Travel$23,051 (10.3%)
Food & Beverage$14,522 (6.5%)
Education$5.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $162,860 | 117 | 72.7% |
| Consulting Fee | $23,467 | 21 | 10.5% |
| Travel and Lodging | $23,051 | 115 | 10.3% |
| Food and Beverage | $14,522 | 514 | 6.5% |
| Education | $5.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $79,637 | 184 | $0 (2024) |
| Mylan Specialty L.P. | $78,208 | 177 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $55,080 | 155 | $0 (2020) |
| GENZYME CORPORATION | $4,816 | 24 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $2,078 | 36 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,391 | 59 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $728.79 | 53 | $0 (2024) |
| Insmed, Inc. | $390.02 | 24 | $0 (2024) |
| Inspire Medical Systems, Inc. | $245.09 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $190.19 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,607 | 126 | Mylan Specialty L.P. ($13,258) |
| 2023 | $22,210 | 130 | AstraZeneca Pharmaceuticals LP ($11,099) |
| 2022 | $12,930 | 71 | AstraZeneca Pharmaceuticals LP ($8,172) |
| 2021 | $22,145 | 54 | AstraZeneca Pharmaceuticals LP ($15,576) |
| 2020 | $13,777 | 32 | Mylan Specialty L.P. ($9,023) |
| 2019 | $45,839 | 158 | Mylan Specialty L.P. ($35,953) |
| 2018 | $40,361 | 91 | Sunovion Pharmaceuticals Inc. ($28,595) |
| 2017 | $37,036 | 106 | Sunovion Pharmaceuticals Inc. ($22,623) |
All Payment Transactions
768 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/17/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/12/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $31.86 | General |
| Category: Narcoplepsy | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $30.89 | General |
| Category: Narcoplepsy | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/27/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: NEUROLOGY | ||||||
| 11/27/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $131.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $12.82 | General |
| Category: Narcoplepsy | ||||||
| 11/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $119.51 | General |
| Category: Immunology | ||||||
| 10/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Insomnia | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $120.27 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.80 | General |
| 10/16/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,010 | 1,228 | $370,803 | $81,453 |
| 2022 | 15 | 1,210 | 1,507 | $427,894 | $102,193 |
| 2021 | 15 | 1,236 | 1,529 | $385,327 | $97,394 |
| 2020 | 15 | 1,168 | 1,606 | $345,996 | $79,784 |
Total Patients
4,624
Total Services
5,870
Medicare Billing
$360,825
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 357 | 490 | $174,440 | $41,177 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 234 | 282 | $68,808 | $16,523 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $32,148 | $8,340 | 25.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 74 | $16,826 | $4,337 | 25.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $10,220 | $2,441 | 23.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 19 | $9,079 | $1,863 | 20.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 19 | 19 | $14,345 | $1,536 | 10.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 19 | 19 | $13,186 | $1,499 | 11.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 14 | 14 | $9,716 | $1,261 | 13.0% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 22 | 22 | $6,270 | $735.46 | 11.7% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 23 | 23 | $6,555 | $668.60 | 10.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 50 | 50 | $2,950 | $415.19 | 14.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 50 | 50 | $2,600 | $308.20 | 11.9% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 30 | 30 | $1,410 | $178.93 | 12.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 25 | 25 | $2,250 | $170.94 | 7.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 422 | 618 | $209,502 | $55,400 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 189 | 209 | $48,697 | $10,991 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 92 | 92 | $37,076 | $10,534 | 28.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 49 | 50 | $18,911 | $4,984 | 26.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 90 | $19,353 | $4,545 | 23.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 57 | $17,442 | $4,151 | 23.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 37 | 37 | $26,640 | $3,381 | 12.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $9,880 | $2,728 | 27.6% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 42 | 42 | $11,424 | $1,309 | 11.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 14 | 14 | $9,268 | $1,231 | 13.3% |
About Dr. Alfred Habel, MD
Dr. Alfred Habel, MD is a Internal Medicine healthcare provider based in Kenosha, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760439608.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alfred Habel, MD has received a total of $223,905 in payments from pharmaceutical and medical device companies, with $29,607 received in 2024. These payments were reported across 768 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($162,860).
As a Medicare-enrolled provider, Habel has provided services to 4,624 Medicare beneficiaries, totaling 5,870 services with total Medicare billing of $360,825. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Kenosha, WI
- Active Since 05/27/2006
- Last Updated 09/15/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1760439608
Products in Payments
- Yupelri (Drug) $58,258
- BREZTRI (Drug) $44,413
- LONHALA MAGNAIR (Drug) $24,380
- UTIBRON (Drug) $22,854
- YUPELRI (Drug) $19,951
- BEVESPI AEROSPHERE (Drug) $18,853
- SYMBICORT (Drug) $7,652
- Utibron (Drug) $5,295
- DUPIXENT (Biological) $4,845
- BREZTRI AEROSPHERE (Drug) $3,101
- SEEBRI (Drug) $2,492
- Wakix (Drug) $1,577
- NUCALA (Biological) $1,191
- XYWAV (Drug) $536.89
- AIRSUPRA (Drug) $516.48
- WAKIX (Drug) $501.09
- Arikayce (Drug) $390.02
- TEZSPIRE (Biological) $300.77
- Inspire Upper Airway Stimulation System (Device) $215.09
- XOLAIR (Biological) $190.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kenosha
Dr. Hasnain Bawaadam, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $473,003
Internal Medicine $473,003
Rosanna Ranieri, Md, MD
Internal Medicine — Payments: $64,322
Internal Medicine $64,322
Mario Garretto, Md, MD
Internal Medicine — Payments: $8,717
Internal Medicine $8,717
Dr. Sudip Ringwala, D.o, D.O
Internal Medicine — Payments: $6,114
Internal Medicine $6,114
Dr. Rodrigo Mata, M.d, M.D
Internal Medicine — Payments: $5,201
Internal Medicine $5,201
Stefanie Ruffolo, M.d, M.D
Internal Medicine — Payments: $4,858
Internal Medicine $4,858